Registry for Molecular Testing, Treatment and Outcome of Patients With Solid Tumors Harboring a NTRK Gene Fusion
NCT04557813 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 88
Last updated 2025-05-01
Summary
The objective of this registry is to analyze treatment reality and outcome of patients with locally advanced or metastatic solid tumors harboring a fusion of NTRK1, NTRK2 or NTRK3
Conditions
- NTRK Family Gene Mutation
Sponsors & Collaborators
-
Roche Pharma AG
collaborator INDUSTRY -
iOMEDICO AG
lead INDUSTRY
Principal Investigators
-
Benjamin Kasenda, PD Dr. Dr. · Universitätsspital Basel, Petersgraben 4, 4031 Basel, Switzerland
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-12-02
- Primary Completion
- 2024-12-31
- Completion
- 2024-12-31
Countries
- Germany
- Switzerland
Study Locations
More Related Trials
-
Molecular and Genomic Profiling of Head and Neck Tumors
NCT00200486 ·Status: RECRUITING
-
Target Gene Sequencing for Advanced Stage, Relapsed or Refractory Natural Killer/T-cell Lymphoma
NCT04509804 ·Status: COMPLETED
-
Tissue Collection for Correlation Between ATM Alterations by Next-Generation Sequencing and ATM Loss-of-Protein
NCT04976803 ·Status: COMPLETED
-
Clinical Tumor Anemia Registry (TAR)
NCT01795690 ·Status: COMPLETED
-
National Register of Actionable Mutations
NCT05918666 ·Status: ACTIVE_NOT_RECRUITING
-
Newer Therapeutic Targets in Head and Neck Cancers
NCT05382585 ·Status: RECRUITING
-
GENomic PROfilation for Therapeutic Purposes in SARComas and Molecular Tumor Board (MTB): Retrospective/Prospective Study in Referral Centers
NCT06076070 ·Status: UNKNOWN
-
Marker Assisted Selective ThErapy in Rare Cancers: Knowledge Database Establishing registrY Asia
NCT05217407 ·Status: RECRUITING
-
Prediction of Residual Disease by Circulating DNA Detection After Potentiated Radiotherapy for Locally Advanced Head and Neck Cancer
NCT05710679 ·Status: RECRUITING ·Phase: NA
-
Genomic Testing and Resulting Medical Decisions
NCT03301493 ·Status: COMPLETED
-
Cancer Predisposition Testing by Family-based Whole-genome Sequencing (WGS) in Every Child With Newly Diagnosed Cancer
NCT04903782 ·Status: RECRUITING
-
Prognostic Markers for a Better Follow-up in Head and Neck Cancer.
NCT06094985 ·Status: RECRUITING
-
A Collection of Clinical and Epidemiologic Data Combined With Tissue and Blood From Patients With a Diagnosis of Neuroendocrine Tumors
NCT00745381 ·Status: COMPLETED
-
Mutational Oncology in Clinical Practice
NCT06020625 ·Status: RECRUITING ·Phase: NA
-
Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment
NCT02105168 ·Status: UNKNOWN ·Phase: NA
-
Characterization & Comparison of Drugable Mutations in Primary and Metastatic Tumors, CTCs and cfDNA in MBCpatients
NCT02626039 ·Status: COMPLETED
-
Optimal Methods of Disease Progression and Survival Analysis in Children and Adults Patients With Adrenocortical Cancer (ACC)
NCT04358107 ·Status: ACTIVE_NOT_RECRUITING
-
The Registry of Oncology Outcomes Associated with Testing and Treatment
NCT04028479 ·Status: COMPLETED
-
Studying Gene Expression in Samples From Patients With Rhabdoid Tumors
NCT01553175 ·Status: COMPLETED
-
Genetic Exploration of the Molecular Basis of Malignancy in Adults
NCT02416518 ·Status: COMPLETED
-
Outcomes of FoundationOne Directed Therapy in Cancer of Unknown Primary
NCT02628379 ·Status: COMPLETED
-
Evaluation of Efficacy of Comprehensive Genomic Tumour Profiling (CGP) From Liquid and/or Tissue Biopsy in Patients With Locally Advanced and/or Metastatic Solid Cancer
NCT05032092 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
New Strategies to Detect Cancers in Carriers of Mutations in RB1
NCT04164134 ·Status: COMPLETED
-
Multicenter Retrospective Database on Prognostic and Predictive Factors in Patients With Neuroendocrine Tumors
NCT05168631 ·Status: ACTIVE_NOT_RECRUITING
-
Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors
NCT03061305 ·Status: TERMINATED